Phenotypic and genotypic characterization of double carbapenemase producing Enterobacterales in a University Hospital
Abstract
The emergence of double-carbapenemase (KPC and NDM) producing Klebsiella pneumoniae isolates is one of the consequences derived from the SARS CoV-2 pandemic, which has caused significant impact on the antimicrobial resistance rates in hospital acquired infections. These isolates represent a real challenge for Health Services due to their difficult detection and characterization and subsequent treatment. In the present work we describe the double carbapenemase producing isolates recovered during the year 2022 from clinical samples belonging to hospitalized patients at a University Hospital in Buenos Aires city, we report their phenotypic and genotypic characterization and the excellent activity of the ceftazidime-avibactam-aztreonam combination in the treatment of infections in which the therapeutical options are restricted to non β- lactamic antimicrobials which hold resistance rates higher than 70%.
Downloads
References
2. Cejas D, Fernandez Canigia L, Nastro M, Rodríguez C, Tanco A, Rodríguez H, Vay C, Maldonado I, Famiglietti A, Giovanakis M, Magariños F, Berardinelli E, Neira L, Mollerach M, Gutkind G, Radice M. Hyperendemic clone of KPC producing Klebsiella pneumoniae ST258 in Buenos Aires hospitals. Infect Genet Evol. 2012 Apr;12(3):499-501.
3. Lee CR, Lee JH, Park KS, Kim YB, Jeong BC, Lee SH. Global Dissemination of Carbapenemase-Producing Klebsiella pneumoniae: Epidemiology, Genetic Context, Treatment Options, and Detection Methods. Front Microbiol. 2016 Jun 13; 7:895.
4. Pasteran F, Meo A, Gomez S, Derdoy L, Albronoz E, Faccone D, Guerriero L, Archuby D, Tarzia A, López M, Corso A. Emergence of genetically related NDM-1-producing Providencia rettgeri strains in Argentina. J Glob Antimicrob Resist. 2014 Dec;2(4):344-345.
5. Dortet L, Poirel L, Nordmann P. Worldwide dissemination of the NDM-type carbapenemases in Gram-negative bacteria. Biomed Res Int. 2014; 2014:249856.
6. Rodriguez CH, Maza J, Tamarin S, Nastro M, Vay C, Famiglietti A. In-house rapid colorimetric method for detection of colistin resistance in Enterobacterales: A significant impact on resistance rates. J Chemother. 2019 Nov-Dec;31(7-8):432-435. doi: 10.1080/1120009X.2019.1637557. Epub 2019 Jul 17. PMID: 31311461.
7. Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically. 11th ed. CLSI standard M07. Wayne, PA; 2018.
8. European Committee on Antimicrobial Susceptibility Testing. 2020. Setting Breakpoints for New Antimicrobial Agents, EUCAST SOP 1.1. Basel, Switzerland: EUCAST.
9. Pires J, Novais A, Peixe L. Blue-carba, an easy biochemical test for detection of diverse carbapenemase producers directly from bacterial cultures. J Clin Microbiol. 2013 Dec;51(12):4281-3. doi: 10.1128/JCM.01634-13. Epub 2013 Oct 9. PMID: 24108615; PMCID: PMC3838089.
10. Poirel L, Walsh TR, Cuvillier V, Nordmann P. Multiplex PCR for detection of acquired carbapenemase genes. Diagn Microbiol Infect Dis. 2011; 70:119–23.
11. Zhang X, Li F, Cui S, Mao L, Li X, Awan F, Lv W, Zeng Z. Prevalence and Distribution Characteristics of blaKPC-2 and blaNDM-1 genes in Klebsiella pneumoniae. Infect Drug Resist. 2020 Aug 20; 13:2901-2910.
12. Cervino I, Gonzalez D, Nastro M, Vega J, Reyes AP, et al. In vitro synergistic activity of aztreonam (AZT) plus novel and old β-lactamase inhibitor combinations against metallo-β-lactamase-producing AZT-resistant Enterobacterales. J Med Microbiol. 2021 oct; 70(10).
13. Genç S, Kolaylı F, Özçelik EY. Molecular characterization of carbapenemase producing Klebsiella pneumoniae strains by multiplex PCR and PFGE methods: The first K.pneumoniae isolates co-producing OXA-48/KPC and KPC/NDM in Turkey. J Infect Chemother. 2022 Feb;28(2):192-198.
Copyright (c) 2023 Marcela Nastro, Carla Álvarez, Nicolás Potente, Iván Cervino, Carlos Vay, Ángela Famiglietti, Carlos H. Rodríguez
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
When an article is finally accepted in the journal, its authors assign their economic rights on a non-exclusive basis in favor of the editors, who allow reuse under an “Attribution-NonCommercial-ShareAlike 4.0 International” License (https://creativecommons.org/licenses/by-nc-sa/4.0/deed.es). This implies that the articles can be shared (copy and redistribute the material in any medium or format) and adapted (remix, transform and create another work from the material), as long as the authorship and the original source of publication (journal, publisher and URL of the work) are cited, they are not used for commercial purposes, and the same terms of the license are respected. It is requested to cite the original source of publication.
In addition, the acceptance of the article by the journal implies on the part of the authors the non-submission of the material to other journals or editorial bodies.
